Dr. Frans S. Vanwagenberg, M.D.
Cardiothoracic Surgery (Thoracic Surgery (Cardiothoracic Vascular Surgery) Physician)
- Medicare participating
At a glance
- Medical school
- University of Maryland School of Medicine (2011)
- Years since graduation
- 15
- In the NPI registry since
- 2011
- Medicare patients seen, 2024
- 199
Licensed in Alabama since 2019, according to the Alabama Board of Medical Examiners and Medical Licensure Commission. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2011Medical school: University of Maryland School of Medicine
- 2011Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Thoracic Surgery (Cardiothoracic Vascular Surgery) Physician primary
AL license 38537 (first issued 2019; active) -
Surgery Physician
TX license BP10041442
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Huntsville Hospital Huntsville, AL
- Crestwood Medical Center Huntsville, AL
- Marshall Medical Centers Boaz, AL
- Athens Limestone Hospital Athens, AL
Medical groups
- Hh Heart Center, LLC (93 clinicians)
- East Alabama Heart and Vascular, LLC (29 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 199
- Services billed
- 516
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| New patient office or other outpatient visit, 60-74 minutes | 78 | 78 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 60 | 51 |
| Replacement of aortic valve through the skin and femoral artery | 58 | 58 |
| Established patient office or other outpatient visit, 30-39 minutes | 39 | 34 |
| Ultrasonic guidance during surgery | 32 | 32 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 27 | 27 |
| Harvest of vein using an endoscope | 21 | 21 |
| Coronary artery bypass using artery graft, 1 graft | 19 | 19 |
| Established patient office or other outpatient visit, 40-54 minutes | 13 | 13 |
| Replacement of aortic valve on heart-lung machine | 12 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Metoprolol Tartrate Other prescribers in Huntsville, AL | 98 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Huntsville, AL | 70 |
| Furosemide Other prescribers in Huntsville, AL | 47 |
| Potassium Chloride Other prescribers in Huntsville, AL | 47 |
| Methocarbamol Other prescribers in Huntsville, AL | 44 |
| Amiodarone Hcl Other prescribers in Huntsville, AL | 43 |
| Famotidine Other prescribers in Huntsville, AL | 26 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Huntsville, AL | 23 |
| Amlodipine Besylate Other prescribers in Huntsville, AL | 22 |
| Eliquis (apixaban) Other prescribers in Huntsville, AL | 21 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 9 companies reported 28 payments worth $12,116 in total to this clinician.
| Edwards Lifesciences Corporation | $11,234 |
|---|---|
| Abiomed | $257 |
| Atricure, Inc. | $236 |
| Artivion, Inc. | $142 |
| Abbott Laboratories | $117 |
| Surgical Specialties Corporation (US), Inc. (DBA Corza Medical) | $49.18 |
| Angiodynamics, Inc. | $33.40 |
| Baxter Healthcare | $25.07 |
| Consulting Fee | $10,000 |
|---|---|
| Food and Beverage | $1,519 |
| Travel and Lodging | $597 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Edwards Lifesciences Corporation Oct 29, 2025 | Consulting Fee EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · Transcatheter Heart Valves | $10,000 |
| Edwards Lifesciences Corporation Oct 10, 2025 | Travel and Lodging travel to Chattanooga, TN · in-kind | $597 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $217,740 in research payments for these studies, mostly to the institutions running them.
- Tracking Results of Ablations to Combat AF Registry Generation 2
Atricure, Inc. · Recruiting · NCT05111015
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.